Home
Tag
Jazz Pharmaceuticals plc
1 article
Results
Jazz Pharma Q1 EPS Beats, Revenue +19%
Jazz Pharmaceuticals reported Q1 adjusted EPS $6.34, topping consensus $4.62 by $1.72. Revenue reached $1.07 billion, up 19% YoY and beating the $981.08 million estimate. Shares jumped 4.8% in after‑h